SCHEMBL10068073

SCHEMBL10068073

C=C(C)C(C)(C)c1ccccc1NC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 7/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 6/20 0.41
ALDH1A1 P00352 5/20 0.36
TDP1 Q9NUW8 4/20 0.36
RECQL P46063 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 5/20 0.35
LMNA P02545 4/20 0.35
ATM Q13315 1/20 0.35
GALR3 O60755 1/20 0.35
STAT3 P40763 1/20 0.35
HTR6 P50406 1/20 0.34
TSHR P16473 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14533543 0.78 KDM4E (0.43) POLBKMT2AMAPTALDH1A1RECQL
Hydrochloric Acid SCHEMBL2861569 0.77 POLB (0.49) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL4079663 0.74 POLB (0.50) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL11443930 0.74 ALDH1A1 (0.58) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL14574087 0.73 ALDH1A1 (0.51) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL14037398 0.72 TDP1 (0.38) KMT2AMAPTALDH1A1TDP1HSD17B10
SCHEMBL24746974 0.71 POLB (0.47) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL25477881 0.71 POLB (0.47) POLBMEN1KMT2AMAPTALDH1A1
SCHEMBL12286423 0.71 MMP1 (0.43) MEN1KMT2AMAPTALDH1A1TDP1
SCHEMBL10020282 0.71 CASP6 (0.36) MEN1KMT2AALDH1A1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035346-A1 LUMINESCENT COMPOUNDS SETA BIOMEDICALS, LLC 2012-02-09 US disclosed
US-7947256-B2 Biocompatible fluorescent imaging agents VISEN MEDICAL, INC. (US) 2011-05-24 US disclosed
US-20080317676-A1 Biocompatible Fluorescent Imaging Agents VISEN MEDICAL, INC. 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080317676-A1 Biocompatible Fluorescent Imaging Agents CD47, FIBP, CD68 POLB 4864/4885MEN1 1115/4885KMT2A 4157/4885
US-20120035346-A1 LUMINESCENT COMPOUNDS PHOSPHO1, PGLS, PFAS POLB 1776/4885MEN1 1504/4885KMT2A 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.